The upcoming Union Budget, for the year 2025–26 presents a chance to align priorities with the evolving pharmaceutical landscape in India. We are eager to see how the budget aims to boost the industry through policy adjustments that play a vital role in fostering sustainable growth and ensuring the widespread availability of essential medications nationwide.
Moreover, it is crucial for the government to prioritize boosting investments in research and development (R&D). With strategies and initiatives in place, India has the potential to solidify its position as a hub,for innovative products and environmentally friendly pharmaceutical production.